Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003

MeSH terms

• Adrenergic beta-Antagonists / therapeutic use
• Aged
• Aged, 80 and over
• Angiotensin Receptor Antagonists
• Atenolol / therapeutic use
• Carbazoles / therapeutic use*
• Carvedilol
• Drug Approval*
• Humans
• Hypertension / drug therapy*
• Losartan / therapeutic use*
• Middle Aged
• Myocardial Infarction / drug therapy*
• Propanolamines / therapeutic use*
• Racial Groups / genetics
• Randomized Controlled Trials as Topic / statistics & numerical data
• Receptor, Angiotensin, Type 1
• Renin-Angiotensin System / genetics
• Risk
• Stroke / prevention & control
• Treatment Outcome
• United States
• United States Food and Drug Administration* / legislation & jurisprudence
• United States Food and Drug Administration* / standards